In the second level of our analyses we examined the contribution of RS and age on

sleep. As Table II shows, our analyses revealed that PSG measures differed in response to changes in RS, age, or both, while some differed in response to neither. For example, significant differences in SE, Stage 1 percentage, and REM density were associated primarily with differences in Inhibitors,research,lifescience,medical RS rather than age; differences in TST, Stage 2 percentage, and Stage 4 click here percentage were associated primarily with differences in participant’s ages, rather than their RS. On the other hand, both RS and age were related significantly to differences in SL, Stage 3 percentage, and SWS percentage. Finally, WASO, REM percentage, and REM latency did not vary significantly with changes in either RS or age. To Inhibitors,research,lifescience,medical examine

these results more completely we ran a separate multivariate analysis on RS, including age as a covariale in those instances where age contributed substantially to the Inhibitors,research,lifescience,medical dependent variable (s) of interest. Results of these analyses showed that menstruating women had significantly shorter SL than postpartum women and greater SE than menopausal women. Menstruating women also had significantly less light (Stage 1 percentage) sleep relative to pregnant and menopausal women and less Stage 3 percentage sleep than pregnant and postpartum women. Postpartum women, however, appeared to have the most deep sleep (highest SWS percentage) of the groups, Inhibitors,research,lifescience,medical especially when compared with menstruating women. Since this is a novel investigation examining PSG sleep across RS, it is unclear how these findings relate to previously published literature, on specific RS groups. The observation that postpartum women had the most SWS activity could be interpreted in the light of likely sleep pressure brought on by infant care needs. Since the PSG

was performed in a clinic environment, it is possible that postpartum women may have been able to use this Inhibitors,research,lifescience,medical setting to “catch up” on needed rest while experiencing a break from their normal nocturnal responsibilities at home. When age was examined separately in the multivariate analyses using RS as a covariate age groups differed on several PSG variables. More specifically, the paired comparison Rolziracetam data (Figure 3) showed that older women (46 years old+) had significantly less TST than younger women (19 to 36 years old), more Stage 2 percentage than women 19 to 36 years old, less Stage 3 percentage sleep than women 19 to 36 years old, and considerably less Stage 4 percentage and SWS percentage than women 19 to 45 years old. Only SL appeared to be problematic for younger women as 19 to 26 years old had significantly longer SL than older (46+ years old) women.